Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
Duke University azithromycin, 2020 | randomized controlled trial | cancelled by investigator | Discontinuated : Poor recruitment, strong evidence from larger trials of no therapeutic benefit | ||
Delliere, 2020 | retrospective cohort | no clinically relevant endpoint | The main objective of this study was to determine invasive pulmonary aspergillosis (IPA) incidence in the COVID-19 patients admitted to the intensive care unit (ICU), describe the patient characteristics associated with its occurrence and evaluate the impact on prognosis. |
Delliere S et al. Clinical Microbiology and Infection 10.1016/j.cmi.2020.12.005 |